Prognostic Impact of Tumor-Infiltrating Lymphocytes and Neutrophils on Survival of Patients with Upfront Resection of Pancreatic Cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic Impact of Tumor-Infiltrating Lymphocytes and Neutrophils on Survival of Patients with Upfront Resection of Pancreatic Cancer
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 1, Pages 39
Publisher
MDPI AG
Online
2019-01-04
DOI
10.3390/cancers11010039
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular classification as prognostic factor and guide for treatment decision of pancreatic cancer
- (2018) David J. Birnbaum et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Comprehensive characterisation of compartment-specific long non-coding RNAs associated with pancreatic ductal adenocarcinoma
- (2018) Luis Arnes et al. GUT
- International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
- (2018) Franck Pagès et al. LANCET
- Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
- (2018) Alexander M.M. Eggermont et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
- (2018) Leena Gandhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- High immune cell score predicts improved survival in pancreatic cancer
- (2018) Kyösti Tahkola et al. VIRCHOWS ARCHIV
- Pancreatic cancer: disease dynamics, tumor biology and the role of the microenvironment
- (2018) Daniel Ansari et al. Oncotarget
- Pancreatic Ductal Adenocarcinoma: A Strong Imbalance of Good and Bad Immunological Cops in the Tumor Microenvironment
- (2018) Etienne D. Foucher et al. Frontiers in Immunology
- Immune Evasion in Pancreatic Cancer: From Mechanisms to Therapy
- (2018) Neus Martinez-Bosch et al. Cancers
- Tumor–stromal cross-talk modulating the therapeutic response in pancreatic cancer
- (2018) Christopher C.M. Neumann et al. Hepatobiliary & Pancreatic Diseases International
- Tumor microenvironment participates in metastasis of pancreatic cancer
- (2018) Bo Ren et al. Molecular Cancer
- Immune Checkpoint Inhibition for Pancreatic Ductal Adenocarcinoma: Current Limitations and Future Options
- (2018) Derya Kabacaoglu et al. Frontiers in Immunology
- Immune Cell and Stromal Signature Associated With Progression-Free Survival of Patients With Resected Pancreatic Ductal Adenocarcinoma
- (2018) Ujjwal Mukund Mahajan et al. GASTROENTEROLOGY
- Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features
- (2018) Francesco Puleo et al. GASTROENTEROLOGY
- Perivascular Tumor-Infiltrating Leukocyte Scoring for Prognosis of Resected Hepatocellular Carcinoma Patients
- (2018) Markus Schoenberg et al. Cancers
- Cytotoxic tumour-infiltrating T lymphocytes influence outcome in resected pancreatic ductal adenocarcinoma
- (2017) Philipp Lohneis et al. EUROPEAN JOURNAL OF CANCER
- Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study
- (2017) Gloria Romagnoli et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Neoadjuvant chemoradiotherapy of pancreatic cancer induces a favorable immunogenic tumor microenvironment associated with increased major histocompatibility complex class I-related chain A/B expression
- (2017) Takashi Murakami et al. JOURNAL OF SURGICAL ONCOLOGY
- Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
- (2017) Vinod P. Balachandran et al. NATURE
- Prognostic Significance of Tumor-Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Chemotherapy
- (2017) Reza Nejati et al. PANCREAS
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Development of a reliable and accurate algorithm to quantify the tumor immune stroma (QTiS) across tumor types
- (2017) Rainer Christoph Miksch et al. Oncotarget
- The Prognostic Value of Tumor-infiltrating Lymphocytes in Hepatocellular Carcinoma: a Systematic Review and Meta-analysis
- (2017) Wei Yao et al. Scientific Reports
- Myeloid-derived suppressor cells and their role in pancreatic cancer
- (2016) M Pergamo et al. CANCER GENE THERAPY
- Macrophages and pancreatic ductal adenocarcinoma
- (2016) Aida Habtezion et al. CANCER LETTERS
- GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer
- (2016) Paola Martinelli et al. GUT
- The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasis
- (2016) Bernhard Mlecnik et al. Science Translational Medicine
- Genomic instability in pancreatic adenocarcinoma: a new step towards precision medicine and novel therapeutic approaches
- (2016) Ibrahim H. Sahin et al. Expert Review of Gastroenterology & Hepatology
- Expansion of tumor-infiltrating lymphocytes (TIL) from human pancreatic tumors
- (2016) MacLean Hall et al. Journal for ImmunoTherapy of Cancer
- Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer
- (2015) T. Donnem et al. ANNALS OF ONCOLOGY
- Prognostic and predictive value of immunological parameters for chemoradioimmunotherapy in patients with pancreatic adenocarcinoma
- (2015) S Karakhanova et al. BRITISH JOURNAL OF CANCER
- Intratumoral tertiary lymphoid organ is a favourable prognosticator in patients with pancreatic cancer
- (2015) N Hiraoka et al. BRITISH JOURNAL OF CANCER
- Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: A meta-analysis
- (2015) Jian-Jun Yang WORLD JOURNAL OF GASTROENTEROLOGY
- Accumulation of FOXP3+T-cells in the tumor microenvironment is associated with an epithelial-mesenchymal-transition-type tumor budding phenotype and is an independent prognostic factor in surgically resected pancreatic ductal adenocarcinoma
- (2015) Martin Wartenberg et al. Oncotarget
- Characterization of myeloid leukocytes and soluble mediators in pancreatic cancer: importance of myeloid-derived suppressor cells
- (2015) Svetlana Karakhanova et al. OncoImmunology
- Immunoscoring breast cancer: TILs remember what they target
- (2014) G. Curigliano et al. ANNALS OF ONCOLOGY
- Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer
- (2014) M.-G. Anitei et al. CLINICAL CANCER RESEARCH
- The role of quantitative mass spectrometry in the discovery of pancreatic cancer biomarkers for translational science
- (2014) Daniel Ansari et al. Journal of Translational Medicine
- An Increased Abundance of Tumor-Infiltrating Regulatory T Cells Is Correlated with the Progression and Prognosis of Pancreatic Ductal Adenocarcinoma
- (2014) Yichen Tang et al. PLoS One
- Pancreatic Ductal Adenocarcinoma Contains an Effector and Regulatory Immune Cell Infiltrate that Is Altered by Multimodal Neoadjuvant Treatment
- (2014) Kendall C. Shibuya et al. PLoS One
- The presence of tumour-associated lymphocytes confers a good prognosis in pancreatic ductal adenocarcinoma: an immunohistochemical study of tissue microarrays
- (2013) Nilanjana Tewari et al. BMC CANCER
- Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer
- (2013) Y Ino et al. BRITISH JOURNAL OF CANCER
- Two immune faces of pancreatic adenocarcinoma: possible implication for immunotherapy
- (2013) Alexandr V. Bazhin et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Overcoming immunosuppression as a new immunotherapeutic approach against pancreatic cancer
- (2013) Alexandr V Bazhin et al. OncoImmunology
- CA19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Perioperative Therapy
- (2012) Werner Hartwig et al. ANNALS OF SURGICAL ONCOLOGY
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Low-dose gemcitabine depletes regulatory T cells and improves survival in the orthotopic Panc02 model of pancreatic cancer
- (2012) Ivan Shevchenko et al. INTERNATIONAL JOURNAL OF CANCER
- The immune score as a new possible approach for the classification of cancer
- (2012) Jérôme Galon et al. Journal of Translational Medicine
- Prognosis of resected pancreatic cancer: is the refined resection margin status dispensable?
- (2012) Werner Hartwig et al. LANGENBECKS ARCHIVES OF SURGERY
- The role of stroma in pancreatic cancer: diagnostic and therapeutic implications
- (2012) Mert Erkan et al. Nature Reviews Gastroenterology & Hepatology
- The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis
- (2011) M J M Gooden et al. BRITISH JOURNAL OF CANCER
- The Desmoplastic Stroma Plays an Essential Role in the Accumulation and Modulation of Infiltrated Immune Cells in Pancreatic Adenocarcinoma
- (2011) Vegard Tjomsland et al. Clinical & Developmental Immunology
- Tumor-infiltrating neutrophils in pancreatic neoplasia
- (2011) Michelle D Reid et al. MODERN PATHOLOGY
- Tissue microarrays: one size does not fit all
- (2010) Jeanette E Eckel-Passow et al. Diagnostic Pathology
- The role of alcohol and smoking in pancreatitis
- (2010) Dhiraj Yadav et al. Nature Reviews Gastroenterology & Hepatology
- Limitations of tissue microarrays compared with whole tissue sections in survival analysis
- (2010) M. HAYSAM KHOUJA et al. Oncology Letters
- Epidemiology of pancreatic cancer: an overview
- (2009) Sara Raimondi et al. Nature Reviews Gastroenterology & Hepatology
- Tissue microarrays compared with whole sections and biochemical analyses. A subgroup analysis of DBCG 82 b&c.
- (2008) M. Kyndi et al. ACTA ONCOLOGICA
- The Activated Stroma Index Is a Novel and Independent Prognostic Marker in Pancreatic Ductal Adenocarcinoma
- (2008) Mert Erkan et al. Clinical Gastroenterology and Hepatology
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started